Low Muscle Mass in Patients Receiving Hemodialysis: Correlations with Vascular Calcification and Vascular Access

Seok-Hyung Kim1, Gwangho Choi1, Youngjin Song1

  • 1Department of Internal Medicine, Chuncheon Sacred Heart Hospital, Chuncheon 24253, Korea.

Insights

Low muscle mass (LMM) is linked to increased vascular calcification (VC) and vascular access failure in hemodialysis patients. Quantifying LMM may help predict access failure, highlighting a new risk factor in chronic kidney disease management.

Area of Science:

  • Nephrology
  • Geriatrics
  • Radiology

Background:

  • Sarcopenia, an age-related decline in muscle mass and strength, is a growing concern.
  • Vascular calcification (VC) is prevalent in chronic kidney disease (CKD) patients and linked to cardiovascular disease.
  • The relationship between low muscle mass (LMM) and vascular access failure in CKD patients requires further investigation.

Purpose of the Study:

  • To investigate the correlation between quantified vascular calcification score (VCS) in arm vascular access and LMM.
  • To determine if LMM is associated with the incidence of vascular access failure in hemodialysis patients.

Main Methods:

  • Vascular calcification score (VCS) was measured using computed tomography (CT) and the Agatston method.
  • Low muscle mass (LMM) was defined as skeletal muscle mass below the median, assessed by bioelectrical impedance.
  • Logistic regression analyses were used to explore the relationship between LMM and VC, and vascular access failure.

Main Results:

  • Low muscle mass (LMM) was independently associated with increased vascular calcification (VC) (HR, 10.415; p = 0.002).
  • Patients with LMM had a significantly higher risk of vascular access failure (HR, 3.652; p = 0.03).
  • Vascular calcification (VC) fully mediated the relationship between LMM and recurrent vascular access failure.

Conclusions:

  • Low muscle mass (LMM), quantified by bioimpedance analysis, is associated with vascular access failure in hemodialysis patients.
  • LMM increases the risk of vascular calcification (VC).
  • LMM has potential as a predictor of vascular access failure in CKD patients.

Related Concept Videos

Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
199
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
296
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
476
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
176
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
166
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
159